Tonix gives update on development of its single-dose live attenuated virus vaccine candidate for… EP News Bureau Aug 21, 2024 TNX-801 is a live replicating attenuated vaccine candidate based on horsepox that is believed to provide immune protection with…
Tonix Pharmaceuticals and Southern Research COVID-19 vaccine provides a novel vector EP News Bureau Jun 27, 2020 As horsepox virus may have been accidentally extirpated there has most likely been no previous exposure to the vector, and any…
